Fukuhara T
Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1988 Jul;63(4):616-23.
Hematopoietic reconstitution in the allogeneic chimera is an important issue because its failure causes fatal infection in the host. Although graft-versus-host disease (GVHD) often occurs and is a major obstacle for successful bone marrow transplantation (BMT), it does not always play an unfavorable role in the host. It has been suggested that GVHD may show some effects on the hematopoietic reconstitution. In order to elucidate mechanism of the influence of GVHD on the hematopoiesis, I have studied kinetics of the hematopoietic progenitor cells in the bone marrow chimeric mice and the effects of spleen cells on it using in vitro CFU-GM assay. The number of CFU-GM in the bone marrow obtained from the allogeneic chimeras were reduced in the very early phase after BMT compared to that of syngeneic bone marrow chimeras. After then, the CFU-GM number in the allogeneic chimeras increased rapidly, especially in the chimeras showing a sign of severe GVHD. Addition of spleen cells from syngeneic chimeras to the bone marrow cell cultures showed no influence on the CFU-GM number observed. However, addition of spleen cells from allogeneic chimeras at 14 days after BMT to the bone marrow cells increased the CFU-GM number. By contrast, the chimeric spleen cells at 21 days after BMT decreased the number. These biphasic effects of spleen cells from allogeneic chimeras on the CFU-GM were considered to be mediated by some kinds of colony stimulating and inhibiting factors. Intraperitoneal injections of recombinant granulocyte-colony stimulating factors into bone marrow chimeras increased the number of granulocyte.(ABSTRACT TRUNCATED AT 250 WORDS)
异基因嵌合体中的造血重建是一个重要问题,因为其失败会导致宿主发生致命感染。尽管移植物抗宿主病(GVHD)经常发生,并且是成功进行骨髓移植(BMT)的主要障碍,但它在宿主中并不总是起不利作用。有人提出,GVHD可能对造血重建有一些影响。为了阐明GVHD对造血作用的影响机制,我利用体外CFU-GM测定法研究了骨髓嵌合小鼠中造血祖细胞的动力学以及脾细胞对其的影响。与同基因骨髓嵌合体相比,异基因嵌合体在BMT后非常早期从骨髓中获得的CFU-GM数量减少。此后,异基因嵌合体中的CFU-GM数量迅速增加,尤其是在出现严重GVHD迹象的嵌合体中。将同基因嵌合体的脾细胞添加到骨髓细胞培养物中对观察到的CFU-GM数量没有影响。然而,在BMT后14天将异基因嵌合体的脾细胞添加到骨髓细胞中会增加CFU-GM数量。相比之下,BMT后21天的嵌合脾细胞会减少数量。异基因嵌合体的脾细胞对CFU-GM的这些双相作用被认为是由某些集落刺激和抑制因子介导的。向骨髓嵌合体腹腔注射重组粒细胞集落刺激因子会增加粒细胞数量。(摘要截断于250字)